Microbiology & Infectious Diseases

Individuals who experience multiple COVID-19 infections are at greater risk of developing post-acute sequelae of COVID-19.

Research has identified microRNAs as potential biomarkers for predicting COVID-19-related mortality in patients with cancer.

Nasal microbiota transplantation could revolutionise the treatment of chronic rhinosinusitis and respiratory tract infections.

Aztreonam–avibactam is a promising treatment for complicated intra-abdominal infections and hospital-acquired or ventilator-associated pneumonia caused by Gram-negative bacteria.

Elevated uric acid levels in children with severe malaria are associated with significantly increased risks of death and long-term cognitive impairment.

A novel clinical decision support system, TBorNotTB, has been developed to assist clinicians in diagnosing pulmonary tuberculosis in low-prevalence settings.

Women are at a significantly higher risk of developing long COVID compared to men, especially between the ages of 40–55 years.

The CROSS score has been developed to accurately predict the risk of intensive care unit admission for patients with COVID-19 who present at the emergency room.